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The purpose of this study was to elucidate whether an enhanced skin radiation reaction correlated
with an enhanced chromosome radiation response. Twelve patients with late radiation skin ulcers
formed after courses of radiation therapy were chosen as a group of individuals with elevated skin
radiosensitivity. Half of the venous blood samples from each donor were irradiated with 2 Gy
trays; the other half remained unexposed. Using standard cytogenetic technique, lymphocyte
cultures were prepared with all samples. On the metaphase preparations, all chromosome
aberrations detectable without karyotype identification were scored. The frequency of various
aberrations in each patient were compared with relevant mean values in healthy unexposed
donors. In several patients, the frequency of one aberration type or another exceeded the control
value significantly. Comparison of aberration patterns in irradiated and nonirradiated cultures and
consideration of elapsed time after therapeutic exposures suggested that the observed increased
aberration levels reflected individual features of the patients' radiosensitivity, rather than lesions
induced by previous in vivo exposures. Therefore, the question of a correlation between skin and
chromosome radiosensitivity can be answered positively. Analysis of the peculiarities of cellular
distribution of aberrations and of the relative contribution of different aberration types in patients
and healthy donors indicates that the investigation of in vitro-induced aberrations is more suitable
for the assessment of individual radiosensitivity than the study of aberrations observed in
unexposed cultures. Environ Health Perspect105(Suppl 6):1437-1439 (1997)
Key words: late radiation injuries, peripheral lymphocytes, chromosome aberrations, human
radiosensitivity
Introduction
In approximately 20% of cases, standard
therapeutic exposures result in formation
oflate radiation skin ulcers (1). Treatment
of late radiation injuries is very compli-
cated, ifnot impossible. One plausible rea-
son for ulcer formation lies in an elevated
individual skin radiosensitivity, and it
would be very useful to be able to select
such sensitive individuals before the onset
ofradiation therapy. In the search for crite-
ria for such a selection, we tried to deter-
mine if individual skin radiosensitivity
correlates with individual chromosome
radiosensitivity measured by chromosome
reaction to in vitro irradiation. In this
study, we used peripheral lymphocytes, as
they have been thoroughly investigated in
radiobiology and cytogenetics, and because
blood radiosensitivity, though by no means
a perfect reflection of the general organ-
ism radiosensitivity, is one of its essential
characteristics. To date, we have examined
12 patients in the clinic of the Medical
Radiology Research Center (Obninsk)
with late radiation skin injuries. These
patients are regarded as persons with possi-
bly elevated individual skin radiosensitiv-
ity. The response oftheir chromosomes to
in vitro irradiation has been compared with
the response in healthy individuals.
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Abbreviation used: Gy, gray.
Methods
Venous blood samples were taken from
12 patients who experienced standard local
therapeutic exposures and from seven
healthy unexposed volunteers. Total expo-
sure doses were approximately 70 Gy; time
periods after exposures are given in the
next section.
One-milliliter aliquots ofwhole hepa-
rinized blood were exposed in culture flasks
to 2 Gy of60Co y-rays at 20 rad/min. Nine
milliliters of minimal essential medium
containing glutamine, bovine serum (15%),
penicillin, and phytohemagglutinin was
added immediately to both irradiated and
nonirradiated blood samples. After 51 hr
incubation at 37°C (with colchicine added
for the final 3 hr) the cells were treated with
hypotonic KCI, fixed with ethanol/acetic
acid (3/1) mixture, spread onto slides, and
stained with azur-eosine.
Metaphases with 45 to 47 chromosomes
were analyzed and all aberrations detectable
without karyotype identification were
scored. Dicentrics, centric rings, detectable
symmetrical translocations, double acentric
rings (including minutes), and free double
fragments were registered as chromosome-
type aberrations, whereas all kinds of intra-
and interchromatid exchanges, single frag-
ments, and isochromatid aberrations were
ascribed to the chromatid type.
Results and Discussion
In healthy donors the results obtained for
each type of aberration were homogenous
both in unexposed and irradiated cultures
(p> 0.9, chi-square test), so they were
pooled, and the mean values were taken as
control. These values are in accordance
with published data (2,3). The values for
the patients were not homogenous
(p<0.02), so the comparison ofaberration
frequencies with the control values was
made separately (by t-test) for each patient.
The results ofthis comparison are summa-
rized in Table 1, which also shows the time
period between the end of therapeutic
exposure and the date when each patient's
blood sample was taken for this study. The
data marked with asterisks in Table 1 cor-
respond to an increased frequency ofvari-
ous types of chromosome damage in some
patients above the control level.
Table 1 shows that in 6 of 12 patients
(patients 3, 4, 5, 6, 8, 12), frequency ofone
type of chromosome damage or another
was elevated significantly (p<0.05),
whereas the rest of the patients did not
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Table 1. Frequencies of differenttypes of chromosome damage in cultured lymphocytes from patients with late radiation skin injuries.
Patient No in vitroexposure 2 Gy in vitro
No Time, yearsa AM, % CsF/100 cells CsE/100 cells CtA/100 cells AM/P00cells CsF/100 cells CsE/100 cells CtA/100 cells
Control - 1.88 ±0.48 0.50 ±0.25 0.13 ±0.13 1.38 ±0.41 42.26 ±1.74 18.09 ±1.50 35.81 ±2.11 2.60 ±0.57
1 1.7 4.00 ±1.96 4.00 ±2.00 0.00 1.00 ±1.00 45.00 ±4.97 28.00 ±5.29 35.00 ±5.92 5.00 ±2.24
2 2.1 3.00 ±1.71 0.00 0.00 3.00 ±1.73 49.00 ±5.00 18.00 ±4.24 50.00 ±7.07 5.00 ±2.24
3 0.4 10.00*±3.00 4.00 ±1.97 6.00*±2.39 2.00 ±1.41 46.00 ±4.98 29.00*±5.39 42.00 ±6.48 8.00 ±2.83
4 1.4 23.00*±4.21 10.00*±3.62 11.00*±4.69 14.00*±3.74 57.14 ±8.36 25.71 ±8.57 68.57*±14.00 31.43*±9.48
5 1.6 5.08 ±2.86 1.69 ±1.69 1.69 ±1.69 1.69 ±1.69 58.75*±5.50 25.00 ±5.59 45.00 ±7.50 3.75 ±2.17
6 31 2.00 ±1.40 1.00 ±1.00 1.00 ±1.00 0.00 51.00 ±5.00 30.00*±5.48 33.00 ±5.74 5.00 ±2.24
7 19 6.00 ±2.37 3.00 ±1.73 1.00 ±1.00 2.00 ±1.41 48.67 ±4.08 20.00 ±3.65 27.33 ±4.27 1.33 ±0.94
8 14 8.00*±2.71 3.00 ±2.23 2.00 ±1.41 4.00 ±2.00 60.00*±4.90 29.00*±5.39 47.00 ±6.86 4.00 ±2.00
9 32 2.00 ±1.40 0.00 0.00 2.00 ±1.41 45.00 ±4.97 22.00 ±4.69 34.00 ±5.83 3.00 ±1.73
10 1.0 2.44 ±1.70 1.22 ±1.22 0.00 1.22 ±1.22 38.00 ±4.85 11.00 ±3.32 37.00 ±6.08 0.00
11 14 3.00 ±1.71 2.00 ±1.41 0.00 1.00 ±1.00 36.00 ±4.80 15.00 ±3.87 28.00 ±5.29 1.00 ±1.00
12 32 7.00*±2.55 0.00 0.00 7.00*±2.65 40.00 ±4.90 17.00 ±4.12 29.00 ±5.39 0.00
Abbreviations: AM, aberrant metaphases; CsE, chromosome-type exchanges; CsF, chromosome-type fragments; CtA, chromatid-type aberrations. 'Period between the end of
therapeutic exposure and date whenthe blood sample wastakenforthis study. *Significantly differentfrom control (p< 0.05).
reveal reliable differences from controls at
any of the examined end points. One
should remember that the patients exam-
ined had previously experienced thera-
peutic exposures and their cytogenetic
characteristics mayhave been influenced by
these exposures (4). Therefore, when a
patient reveals an increased level ofchro-
mosome damage the main problem is to
distinguish between the contribution ofan
enhanced individual radiosensitivity and
the contribution of in vivo-induced lesions.
This problem cannot be resolved in the
present study, although some useful infor-
mation can be obtained. Our next step
will be to examine as a control group not
healthy unexposed persons, but a group of
therapeutically exposed patients with no
late radiation ulcers.
For patients 6, 8, and 12, the influence
of therapeutic exposure is unlikely, as
these patients were exposed many years
ago. It is generally accepted that lympho-
cytes with in vivo-induced chromosome
lesions disappear from circulating blood
with a half-life of approximately 3 years
after exposure (5). Patient 5, though irra-
diated only 1.6 years ago, has normal
spontaneous aberration levels, so the
increased level of in vitro-induced damage
probably reflects his elevated individual
radiosensitivity. Patients 4 and 12 reveal
not only an increased rate ofchromosome-
type aberrations, which are known to be
the main result of in vivo exposures, but
an increased rate ofchromatid aberrations
as well. This feature can be regarded as a
peculiarity oftheir individual radiosensi-
tivity. It is interesting to note that in all
cases where the frequency ofchromosome-
type fragments in exposed cultures exceeds
the control value (patients 3, 6, and 8), it
is at the normal level in the unexposed
counterparts. Thus it seems that the
enhanced frequency ofchromosome-type
fragments presents chromosome response
only to in vitro irradiation, without the
contribution oftherapeutic exposure.
Another approach to avoid the influence
of therapeutic irradiation is to subtract
(for each patient) the aberration level
observed in unexposed culture from the
level induced by 2 Gy and compare the
result with the similar control value. The
comparison offrequencies reduced by base
levels renders the detected differences more
reliable, but is less sensitive in detection of
the differences, because relative errors of
calculated reduced frequencies are higher
than those ofinitial frequencies. This analy-
sis corroborated the significant increase of
aberrant metaphase frequency in patients 5
and 8, and ofchromosome-type fragment
frequency in patient 6. Other differences
mentioned above, though still observed,
were statistically insignificant (p>0.05)
using this comparison scheme.
If we regard the results for patients
5, 6, and 8 as the most reliable statisti-
cally and the results for patients 3, 4, and
12 as supportive, we come to the conclu-
sion that at least some of the individuals
with an elevated skin radiosensitivity
also have an increased radiosensitivity of
lymphocyte chromosomes.
The observed heterogeneity ofchromo-
some radiosensitivity among the patients is
not unexpected. In addition to individual
variations in underlying sensitivity, varia-
tions can result from multiple causes
including different time periods elapsed
after in vivo exposure, different individual
rates ofelimination ofaberrant lympho-
cytes from blood, errors in dose estimation
during radiotherapy, imperfect statistical
analyses applied, and other factors. The
results described, obtained from a rather
heterogeneous group of patients and
still evidencing a correlation between two
characteristics of radiosensitivity, appear
encouraging for further research.
We regard the aberration pattern
observed in cultures exposed in vitro as
more suitable for evaluation of individual
radiosensitivity than the aberration pattern
in unexposed cultures because it appears
that in vitro reaction is less dependent on
the influence of in vivo exposures. The first
argument favoring this suggestion concerns
cellular distribution of aberrations. In
healthy donors, aberrations are distributed
according to Poisson distribution both in
exposed (p=0.8307) and unexposed
(p=0.8738) cultures. In patients, aberra-
tion distribution is very far from Poisson in
unexposed cultures (p=0.0009), which is
characteristic ofthe effect ofin vivoirradia-
tion ofa part ofthe body (6). In irradiated
cultures, however, it again approaches the
Poisson distribution (p=0.0517), possibly
hinting that previous in vivo exposure does
not distort significantly the pattern ofindi-
vidual in vitro response. The second argu-
ment lies in the relative contribution of
various aberration types in six patients
selected as sensitive compared to the con-
trol pattern (data not shown). This compar-
ison shows that in the unexposed cultures
these patterns are completely different,
implying different origin of spontaneous
aberrations observed in the patients and in
unexposed healthy persons. However, in
the irradiated cultures the patterns observed
in the patients closely resemble the con-
trols. This indicates that when we compare
aberration frequencies in irradiated cultures
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ofpatients with the corresponding control
values, we deal with phenomena ofa simi-
lar nature, which makes the comparison
more reasonable.
The kind oftask we are performing in
this study can be regarded as an approach to
a more general, interesting, and topical prob-
lem-that is, an assessment ofindividual
radiosensitivity. The variety of factors
contributing to human radiosensitivity is
extremely complex; obviously, it cannot be
described with the aid ofsome single and
general value. Its partial characteristics are
numerous. As an indicator ofhuman suscep-
tibility to radiation we suggest the examina-
tion of the radiosensitivity ofperipheral
lymphocytes. This parameter is relevant to
heredity and blood is radiosensitive and
sensitive to alterations ofthe whole-body
state and can be sampled readily in a nonin-
vasive way. The results presented here,
though preliminary, could be useful in this
field ofinvestigation.
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